The peptide, derived from the C-terminal fragment of human growth hormone (amino acids 176-191), targets adipose tissue specifically without the broader metabolic effects associated with full growth hormone therapy
It strengthens supporting muscles, improves spinal mechanics, and creates the movement patterns that promote disc health long-term
Food and Drug Administration (FDA), and are not intended to diagnose, treat, cure, or prevent any disease or medical condition
But until human studies are done, it remains on the frontier of regenerative medicine
It's relatively stable and converts easily into active forms in the body
In some patients with myeloproliferative disorders or liver disease, increased levels of serum haptocorrins result in increases in the measured serum cobalamin level (without actually increasing the physiologically active holotranscobalamin fraction)